HEADER LIGASE 26-MAY-09 3HL5 TITLE CRYSTAL STRUCTURE OF XIAP BIR3 WITH CS3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 4; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: BIR3, UNP RESIDUES 256-346; COMPND 5 SYNONYM: E3 UBIQUITIN-PROTEIN LIGASE XIAP, INHIBITOR OF APOPTOSIS COMPND 6 PROTEIN 3, X-LINKED INHIBITOR OF APOPTOSIS PROTEIN, X-LINKED IAP, COMPND 7 IAP-LIKE PROTEIN, HILP; COMPND 8 EC: 6.3.2.-; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: API3, BIRC4, IAP3, XIAP; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL-21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS BIR, IAP, APOPTOSIS, SMALL MOLECULE DRUG DISCOVERY, STRUCTURE-BASED KEYWDS 2 DRUG DESIGN, LIGASE, METAL-BINDING, PHOSPHOPROTEIN, PROTEASE KEYWDS 3 INHIBITOR, THIOL PROTEASE INHIBITOR, UBL CONJUGATION PATHWAY, ZINC- KEYWDS 4 FINGER EXPDTA X-RAY DIFFRACTION AUTHOR S.G.HYMOWITZ REVDAT 4 06-SEP-23 3HL5 1 REMARK SEQADV LINK REVDAT 3 13-JUL-11 3HL5 1 VERSN REVDAT 2 28-JUL-09 3HL5 1 JRNL REVDAT 1 16-JUN-09 3HL5 0 JRNL AUTH C.NDUBAKU,E.VARFOLOMEEV,L.WANG,K.ZOBEL,K.LAU,L.O.ELLIOTT, JRNL AUTH 2 B.MAURER,A.V.FEDOROVA,J.N.DYNEK,M.KOEHLER,S.G.HYMOWITZ, JRNL AUTH 3 V.TSUI,K.DESHAYES,W.J.FAIRBROTHER,J.A.FLYGARE,D.VUCIC JRNL TITL ANTAGONISM OF C-IAP AND XIAP PROTEINS IS REQUIRED FOR JRNL TITL 2 EFFICIENT INDUCTION OF CELL DEATH BY SMALL-MOLECULE IAP JRNL TITL 3 ANTAGONISTS. JRNL REF ACS CHEM.BIOL. V. 4 557 2009 JRNL REFN ISSN 1554-8929 JRNL PMID 19492850 JRNL DOI 10.1021/CB900083M REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.15 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 3 NUMBER OF REFLECTIONS : 16220 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.209 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.300 REMARK 3 FREE R VALUE TEST SET COUNT : 1855 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 25 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.84 REMARK 3 REFLECTION IN BIN (WORKING SET) : 836 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 84.37 REMARK 3 BIN R VALUE (WORKING SET) : 0.2100 REMARK 3 BIN FREE R VALUE SET COUNT : 87 REMARK 3 BIN FREE R VALUE : 0.3160 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1506 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 146 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 16.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.94 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.71000 REMARK 3 B22 (A**2) : 1.25000 REMARK 3 B33 (A**2) : -0.55000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.03000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.144 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.129 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.077 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.993 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.929 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1645 ; 0.007 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2226 ; 1.126 ; 1.977 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 182 ; 4.413 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 80 ;32.983 ;24.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 248 ;12.769 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 6 ;14.463 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 210 ; 0.073 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1292 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 761 ; 0.191 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1115 ; 0.305 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 120 ; 0.108 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 67 ; 0.152 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 14 ; 0.117 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 934 ; 1.955 ; 2.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1450 ; 2.979 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 845 ; 2.268 ; 2.500 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 776 ; 3.469 ; 5.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 256 A 346 REMARK 3 ORIGIN FOR THE GROUP (A): 6.2673 14.8870 -9.6435 REMARK 3 T TENSOR REMARK 3 T11: -0.0395 T22: -0.0088 REMARK 3 T33: -0.0455 T12: -0.0101 REMARK 3 T13: 0.0078 T23: 0.0024 REMARK 3 L TENSOR REMARK 3 L11: 1.2218 L22: 0.7250 REMARK 3 L33: 0.5811 L12: 0.1179 REMARK 3 L13: 0.1481 L23: -0.0729 REMARK 3 S TENSOR REMARK 3 S11: -0.0172 S12: 0.0645 S13: 0.0739 REMARK 3 S21: -0.0563 S22: -0.0062 S23: -0.0088 REMARK 3 S31: -0.0630 S32: 0.0311 S33: 0.0234 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3HL5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-JUN-09. REMARK 100 THE DEPOSITION ID IS D_1000053268. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-MAR-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : DOUBLE-CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19119 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.790 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : 0.07500 REMARK 200 FOR THE DATA SET : 14.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.79 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.09600 REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: CHAIN D FROM PDB ENTRY 1G73 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: DROPS CONTAIN 2 UL PROTEIN AND 2 UL REMARK 280 WELL SOLUTIONS. PROTEIN SOLUTION: 4 MG/ML IN 20 MM TRIS PH 8.3, REMARK 280 200MM NAL. 2 MM CS3. WELL SOLUTION: 3.5 M NA FORMATE PH 7.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 51.95650 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.97000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 51.95650 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 19.97000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 38 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 252 REMARK 465 GLY B 252 REMARK 465 SER B 253 REMARK 465 HIS B 254 REMARK 465 MET B 255 REMARK 465 HIS B 346 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 302 -65.74 -90.81 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 502 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 300 SG REMARK 620 2 CYS A 303 SG 107.5 REMARK 620 3 HIS A 320 NE2 99.2 116.5 REMARK 620 4 CYS A 327 SG 115.1 109.2 109.2 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 502 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 300 SG REMARK 620 2 CYS B 303 SG 108.2 REMARK 620 3 HIS B 320 NE2 105.0 112.3 REMARK 620 4 CYS B 327 SG 114.5 111.0 105.6 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 9JZ B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 9JZ A 1 DBREF 3HL5 A 256 346 UNP P98170 XIAP_HUMAN 256 346 DBREF 3HL5 B 256 346 UNP P98170 XIAP_HUMAN 256 346 SEQADV 3HL5 GLY A 252 UNP P98170 EXPRESSION TAG SEQADV 3HL5 SER A 253 UNP P98170 EXPRESSION TAG SEQADV 3HL5 HIS A 254 UNP P98170 EXPRESSION TAG SEQADV 3HL5 MET A 255 UNP P98170 EXPRESSION TAG SEQADV 3HL5 GLY B 252 UNP P98170 EXPRESSION TAG SEQADV 3HL5 SER B 253 UNP P98170 EXPRESSION TAG SEQADV 3HL5 HIS B 254 UNP P98170 EXPRESSION TAG SEQADV 3HL5 MET B 255 UNP P98170 EXPRESSION TAG SEQRES 1 A 95 GLY SER HIS MET LEU PRO ARG ASN PRO SER MET ALA ASP SEQRES 2 A 95 TYR GLU ALA ARG ILE PHE THR PHE GLY THR TRP ILE TYR SEQRES 3 A 95 SER VAL ASN LYS GLU GLN LEU ALA ARG ALA GLY PHE TYR SEQRES 4 A 95 ALA LEU GLY GLU GLY ASP LYS VAL LYS CYS PHE HIS CYS SEQRES 5 A 95 GLY GLY GLY LEU THR ASP TRP LYS PRO SER GLU ASP PRO SEQRES 6 A 95 TRP GLU GLN HIS ALA LYS TRP TYR PRO GLY CYS LYS TYR SEQRES 7 A 95 LEU LEU GLU GLN LYS GLY GLN GLU TYR ILE ASN ASN ILE SEQRES 8 A 95 HIS LEU THR HIS SEQRES 1 B 95 GLY SER HIS MET LEU PRO ARG ASN PRO SER MET ALA ASP SEQRES 2 B 95 TYR GLU ALA ARG ILE PHE THR PHE GLY THR TRP ILE TYR SEQRES 3 B 95 SER VAL ASN LYS GLU GLN LEU ALA ARG ALA GLY PHE TYR SEQRES 4 B 95 ALA LEU GLY GLU GLY ASP LYS VAL LYS CYS PHE HIS CYS SEQRES 5 B 95 GLY GLY GLY LEU THR ASP TRP LYS PRO SER GLU ASP PRO SEQRES 6 B 95 TRP GLU GLN HIS ALA LYS TRP TYR PRO GLY CYS LYS TYR SEQRES 7 B 95 LEU LEU GLU GLN LYS GLY GLN GLU TYR ILE ASN ASN ILE SEQRES 8 B 95 HIS LEU THR HIS HET ZN A 502 1 HET 9JZ A 1 37 HET ZN B 502 1 HET 9JZ B 1 37 HETNAM ZN ZINC ION HETNAM 9JZ (3S)-1-{(2S)-2-CYCLOHEXYL-2-[(N-METHYL-L-ALANYL) HETNAM 2 9JZ AMINO]ACETYL}-3-METHYL-N-(2-PYRIMIDIN-2-YLPHENYL)-L- HETNAM 3 9JZ PROLINAMIDE FORMUL 3 ZN 2(ZN 2+) FORMUL 4 9JZ 2(C28 H38 N6 O3) FORMUL 7 HOH *146(H2 O) HELIX 1 1 ASN A 259 ALA A 263 5 5 HELIX 2 2 ASP A 264 THR A 271 1 8 HELIX 3 3 ASN A 280 ALA A 287 1 8 HELIX 4 4 ASP A 315 TYR A 324 1 10 HELIX 5 5 CYS A 327 LYS A 334 1 8 HELIX 6 6 GLY A 335 HIS A 343 1 9 HELIX 7 7 ASN B 259 ALA B 263 5 5 HELIX 8 8 ASP B 264 GLY B 273 1 10 HELIX 9 9 ASN B 280 ALA B 287 1 8 HELIX 10 10 ASP B 315 TYR B 324 1 10 HELIX 11 11 CYS B 327 GLY B 335 1 9 HELIX 12 12 GLY B 335 LEU B 344 1 10 SHEET 1 A 3 PHE A 289 ALA A 291 0 SHEET 2 A 3 VAL A 298 CYS A 300 -1 O LYS A 299 N TYR A 290 SHEET 3 A 3 GLY A 306 LEU A 307 -1 O LEU A 307 N VAL A 298 SHEET 1 B 3 PHE B 289 ALA B 291 0 SHEET 2 B 3 VAL B 298 CYS B 300 -1 O LYS B 299 N TYR B 290 SHEET 3 B 3 GLY B 306 LEU B 307 -1 O LEU B 307 N VAL B 298 LINK SG CYS A 300 ZN ZN A 502 1555 1555 2.34 LINK SG CYS A 303 ZN ZN A 502 1555 1555 2.33 LINK NE2 HIS A 320 ZN ZN A 502 1555 1555 2.14 LINK SG CYS A 327 ZN ZN A 502 1555 1555 2.34 LINK SG CYS B 300 ZN ZN B 502 1555 1555 2.33 LINK SG CYS B 303 ZN ZN B 502 1555 1555 2.33 LINK NE2 HIS B 320 ZN ZN B 502 1555 1555 2.05 LINK SG CYS B 327 ZN ZN B 502 1555 1555 2.32 CISPEP 1 LEU B 256 PRO B 257 0 0.31 SITE 1 AC1 4 CYS A 300 CYS A 303 HIS A 320 CYS A 327 SITE 1 AC2 4 CYS B 300 CYS B 303 HIS B 320 CYS B 327 SITE 1 AC3 16 9JZ A 1 HOH A 141 LYS A 322 TRP A 323 SITE 2 AC3 16 PRO A 325 HIS A 346 HOH B 55 GLY B 306 SITE 3 AC3 16 LEU B 307 THR B 308 ASP B 309 TRP B 310 SITE 4 AC3 16 GLU B 314 GLN B 319 TRP B 323 TYR B 324 SITE 1 AC4 12 HOH A 159 GLY A 306 LEU A 307 THR A 308 SITE 2 AC4 12 ASP A 309 GLU A 314 GLN A 319 LYS A 322 SITE 3 AC4 12 TRP A 323 TYR A 324 9JZ B 1 ASP B 309 CRYST1 103.913 39.940 49.929 90.00 100.00 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009623 0.000000 0.001698 0.00000 SCALE2 0.000000 0.025038 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020338 0.00000